JP2001516719A5 - - Google Patents

Download PDF

Info

Publication number
JP2001516719A5
JP2001516719A5 JP2000511500A JP2000511500A JP2001516719A5 JP 2001516719 A5 JP2001516719 A5 JP 2001516719A5 JP 2000511500 A JP2000511500 A JP 2000511500A JP 2000511500 A JP2000511500 A JP 2000511500A JP 2001516719 A5 JP2001516719 A5 JP 2001516719A5
Authority
JP
Japan
Prior art keywords
methylpiperazin
tetrahydro
naphthyl
component
morpholinobenzamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000511500A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001516719A (ja
Filing date
Publication date
Priority claimed from SE9703376A external-priority patent/SE9703376D0/xx
Application filed filed Critical
Publication of JP2001516719A publication Critical patent/JP2001516719A/ja
Publication of JP2001516719A5 publication Critical patent/JP2001516719A5/ja
Pending legal-status Critical Current

Links

JP2000511500A 1997-09-18 1998-09-09 モノアミンオキシダーゼ阻害剤およびh5−HT1Bアンタゴニストまたは部分的アゴニストの組み合わせ Pending JP2001516719A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9703376-5 1997-09-18
SE9703376A SE9703376D0 (sv) 1997-09-18 1997-09-18 A new combination
PCT/SE1998/001602 WO1999013878A1 (en) 1997-09-18 1998-09-09 A COMBINATION OF A MONOAMINE OXIDASE INHIBITOR AND A h5-HT1B ANTAGONIST OR PARTIAL AGONIST

Publications (2)

Publication Number Publication Date
JP2001516719A JP2001516719A (ja) 2001-10-02
JP2001516719A5 true JP2001516719A5 (https=) 2006-01-05

Family

ID=20408296

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000511500A Pending JP2001516719A (ja) 1997-09-18 1998-09-09 モノアミンオキシダーゼ阻害剤およびh5−HT1Bアンタゴニストまたは部分的アゴニストの組み合わせ

Country Status (27)

Country Link
US (1) US6159970A (https=)
EP (1) EP1014986B1 (https=)
JP (1) JP2001516719A (https=)
KR (2) KR20010024084A (https=)
CN (1) CN1278727A (https=)
AR (1) AR013503A1 (https=)
AT (1) ATE270889T1 (https=)
AU (1) AU752719B2 (https=)
BR (1) BR9812236A (https=)
CA (1) CA2302204A1 (https=)
DE (1) DE69825062T2 (https=)
DK (1) DK1014986T3 (https=)
EE (1) EE200000146A (https=)
ES (1) ES2222603T3 (https=)
HU (1) HUP0100621A2 (https=)
ID (1) ID25789A (https=)
IL (1) IL134775A0 (https=)
IS (1) IS5401A (https=)
MX (1) MXPA00002616A (https=)
NO (1) NO20001400L (https=)
PL (1) PL339368A1 (https=)
PT (1) PT1014986E (https=)
SE (1) SE9703376D0 (https=)
SK (1) SK2832000A3 (https=)
TR (1) TR200000725T2 (https=)
WO (1) WO1999013878A1 (https=)
ZA (1) ZA987804B (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4957948A (en) * 1988-05-05 1990-09-18 Interface, Inc. Biocidal protective coating for heat exchanger coils
SE9601110D0 (sv) 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
WO2002066454A1 (fr) * 2001-02-21 2002-08-29 Sankyo Company, Limited Derives de chromene
ATE424825T1 (de) * 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US20090054453A1 (en) * 2006-03-17 2009-02-26 Lilian Alcaraz Novel Tetralins as 5-HT6 Modulators
EP2089383B1 (en) 2006-11-09 2015-09-16 Probiodrug AG 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
US9126987B2 (en) 2006-11-30 2015-09-08 Probiodrug Ag Inhibitors of glutaminyl cyclase
AU2008220785B2 (en) 2007-03-01 2013-02-21 Vivoryon Therapeutics N.V. New use of glutaminyl cyclase inhibitors
JP5667440B2 (ja) 2007-04-18 2015-02-12 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのチオ尿素誘導体
JP5934645B2 (ja) 2009-09-11 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤としてのヘテロ環式誘導体
WO2011107530A2 (en) 2010-03-03 2011-09-09 Probiodrug Ag Novel inhibitors
JP5688745B2 (ja) 2010-03-10 2015-03-25 プロビオドルグ エージー グルタミニルシクラーゼ(qc、ec2.3.2.5)の複素環阻害剤
WO2011131748A2 (en) 2010-04-21 2011-10-27 Probiodrug Ag Novel inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
ES2812698T3 (es) 2017-09-29 2021-03-18 Probiodrug Ag Inhibidores de glutaminil ciclasa
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer
CN110179988A (zh) * 2019-07-10 2019-08-30 王大伟 五羟色胺再摄取抑制剂和单胺氧化酶抑制剂联合在制备治疗抑郁症或早泄药物中的应用
WO2024130044A1 (en) * 2022-12-14 2024-06-20 Luminous Mind Inc. Treatment of psychological factors affecting other medical conditions (pfaomc)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9119932D0 (en) * 1991-09-18 1991-10-30 Glaxo Group Ltd Chemical compounds
PT533268E (pt) * 1991-09-18 2002-02-28 Glaxo Group Ltd Derivados de benzanilida como antagonistas de 5-ht1d
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives

Similar Documents

Publication Publication Date Title
JP2001516718A5 (https=)
JP2001516719A5 (https=)
RU2000109563A (ru) Комбинация обратного поглощения 5-нт селективного антагониста или частичного агониста н5-нт1b
JP2008538741A (ja) 鬱病の治療用及び/又は予防用の医薬組成物
EP3219308A1 (en) Melt-extruded solid dispersions containing an apoptosis-inducing agent
JP2008531714A (ja) 不安障害の治療用及び/又は予防用の医薬組成物
JP2004538259A5 (https=)
JP2008531715A (ja) 統合失調症及び関連疾患の治療用及び/又は予防用の医薬組成物
JP2005501120A5 (https=)
RU2002123350A (ru) Дипептиднитрильные ингибиторы катепсина К
JP2009526821A (ja) 注意欠陥多動性障害治療用の新規な医薬組成物
TW200916103A (en) Therapeutic compositions and methods
RU2005102098A (ru) Амидное производное
JP2018512403A5 (https=)
JP2004509857A5 (https=)
SE9703375D0 (sv) A new combination
TW201912153A (zh) 用於治療b型肝炎的化合物、醫藥組合物及方法
RU97119427A (ru) Сочетание ингибитора усвоения 5-нт с селективным 5-нтia антагонистом
SE9703376D0 (sv) A new combination
JP2001516717A5 (https=)
RU2000109558A (ru) Комбинация селективного антагониста 5-нт1a и селективного антагониста или частичного агониста н5-нт1b
JP2021503457A5 (https=)
JPWO2021129653A5 (https=)
RU2007101522A (ru) Диарилметилпиперазиновые производные, их получение и применение
RU2005135649A (ru) Комбинации пароксетина и 4-(s)-(4-ацетилпиперазин-1-ил)-2-(r)-(4-фтор-2-метилфенил)пиперидин-1-карбоновой кислоты [1-(r)-(3, 5-бис-трифторметилфенил)этил]метиламида для лечения депрессии и/или тревоги